Breaking News Bar

Business News and Information

Editas Medicine: CRISPR Gene Editing Leader

Editas is focused on the CRISPR gene-editing technology, which promises solutions to hereditary and chronic diseases. An exciting story, but is it investable?
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear